GSK-3

Glycogen Synthase Kinase 3 (GSK-3)

File:GSK3 active site.png

Active site of GSK-3

Glycogen Synthase Kinase 3 (GSK-3) is a serine/threonine protein kinase that is involved in a wide range of cellular processes, including glycogen metabolism, cell signaling, and cellular proliferation. GSK-3 is highly conserved across species and plays a critical role in various signaling pathways.

Structure

GSK-3 is composed of two isoforms, GSK-3_ and GSK-3_, which are encoded by separate genes. Both isoforms share a high degree of sequence similarity and have a similar three-dimensional structure. The active site of GSK-3, as depicted in the image, is crucial for its kinase activity, allowing it to phosphorylate target proteins.

Function

GSK-3 is involved in the regulation of several key cellular processes:

• Glycogen Metabolism: GSK-3 phosphorylates and inactivates glycogen synthase, the enzyme responsible for converting glucose to glycogen. This regulation is crucial for maintaining glucose homeostasis.

• Wnt Signaling Pathway: In the absence of Wnt signals, GSK-3 phosphorylates _-catenin, targeting it for degradation. This prevents the activation of Wnt target genes. When Wnt is present, GSK-3 is inhibited, allowing _-catenin to accumulate and activate transcription.

• Insulin Signaling: GSK-3 is inhibited by insulin signaling, which leads to the activation of glycogen synthase and increased glycogen synthesis.

• Neurotransmission: GSK-3 is involved in the regulation of neurotransmitter release and synaptic plasticity, impacting learning and memory.

Clinical Significance

GSK-3 has been implicated in several diseases, including:

• Diabetes: Due to its role in insulin signaling, dysregulation of GSK-3 activity can contribute to insulin resistance and type 2 diabetes.

• Alzheimer's Disease: GSK-3 is involved in the phosphorylation of tau protein, a process that is associated with the formation of neurofibrillary tangles in Alzheimer's disease.

• Cancer: GSK-3 can act as both a tumor suppressor and a promoter, depending on the cellular context and the signaling pathways involved.

Inhibition and Therapeutic Potential

GSK-3 inhibitors are being explored as potential therapeutic agents for a variety of conditions, including mood disorders, neurodegenerative diseases, and cancer. The development of selective GSK-3 inhibitors is an active area of research.

Related Pages

• Protein kinase
• Signal transduction
• Glycogen metabolism
• Wnt signaling pathway
• Insulin signaling